An Adaptive Design Study of MTX228

Abroad (travel likely)RecruitingPHASE2

Conditions

Type 1 Diabetes Mellitus

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

University of Alberta, Edmonton, Alberta, Canada
Contact: Study coordinator (Dominque Forrest) · dforres1@ualberta.ca
Contact: Study coordinator (Peter Senior, MD) · psenior@ualberta.ca

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)

Type 1 Diabetes Mellitus · T1D · T1DM

Abroad (travel likely)RecruitingPHASE1, PHASE2

Tucson, United States · Tucson, United States

Safety, Tolerability, and Efficacy of Immunomodulation With A Monoclonal Antibody Against CD40L in Combination With Transplanted Islet Cells in Adults With Brittle Type 1 Diabetes Mellitus (T1D)

Type 1 Diabetes Mellitus

Abroad (travel likely)RecruitingPHASE1, PHASE2

Chicago, United States

A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes Mellitus

Diabetes Mellitus, Type 1 · Hypoglycemia · Islet Cell Transplantation

Abroad (travel likely)RecruitingPHASE1, PHASE2

Chicago, United States

Safety and Efficacy of CELZ-201 in Patients With Recent Onset Type 1 Diabetes

Type 1 Diabetes · Diabetes Mellitus, Type 1

Abroad (travel likely)RecruitingPHASE1, PHASE2

Miami, United States